We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
134 hedge funds and large institutions have $260M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
18% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 40
6% more funds holding
Funds holding: 126 → 134 (+8)
0% less call options, than puts
Call options by funds: $1.89M | Put options by funds: $1.9M
25% less capital invested
Capital invested by funds: $347M → $260M (-$87.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
134
Holders Change
+8
Holders Change %
+6.35%
% of All Funds
2.06%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
47
Reduced
40
Closed
12
Calls
$1.89M
Puts
$1.9M
Net Calls
-$7K
Net Calls Change
-$245K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.3M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.59M |
| 3 |
Millennium Management
New York
|
+$1.51M |
| 4 |
BlackRock
New York
|
+$1.3M |
| 5 |
Rafferty Asset Management
New York
|
+$956K |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$7.6M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.72M |
| 3 |
HF
HRT Financial
New York
|
-$929K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$894K |
| 5 |
E
Ergoteles
New York
|
-$532K |
